Fundz

Sensible Biotechnologies Raises $4.2Mn In A Pre-Seed Financing Round To Revolutionize Mrna Manufacturing

PRIVATEApr 06, 2023

Amount Raised

$4.2 Million

Round Type

Pre-Seed

OxfordBiotechnology

Investors

DLA PiperJason C. FosterFlorian SchusterZakaRecode Health VenturesCivilization VenturesAmino CollectiveY CombinatorBlue Yard Capital

Description

Sensible Biotechnologies, Inc., an mRNA platform company, has announced a $4.2mn pre-seed round to accelerate the development of its cell-based platform for cost-efficient manufacturing of high-quality mRNA. The company's technology aims to overcome the limitations of current mRNA manufacturing processes, ensuring scalable and cost-effective production of mRNA with high quality.

Quick answer

Sensible Biotechnologies raised $4.2 Million in a Pre-Seed round, dated April 6, 2023. Investors: DLA Piper, Jason C. Foster, Florian Schuster, Zaka, Recode Health Ventures, Civilization Ventures, Amino Collective and Y Combinator. Sensible Biotechnologies is based in Oxford, England, United Kingdom.

How much did Sensible Biotechnologies raise?
Sensible Biotechnologies raised $4.2 Million in a Pre-Seed round on April 6, 2023.
Who invested in Sensible Biotechnologies?
DLA Piper, Jason C. Foster, Florian Schuster, Zaka, Recode Health Ventures, Civilization Ventures, Amino Collective and Y Combinator are named as investors in this round.
What does Sensible Biotechnologies do?
Sensible Biotechnologies is building a cell-based platform for the production of high-quality mRNA.
Where is Sensible Biotechnologies based and how big is it?
Sensible Biotechnologies is based in Oxford, England, United Kingdom. Fundz records about 35 employees.
Who are the decision-makers at Sensible Biotechnologies?
Fundz holds 2 contacts at Sensible Biotechnologies, including the CEO and Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Sensible Biotechnologies that raised within 45 days of this round, from Fundz verified event records.

  • SURGE Therapeutics raised $32M on May 19, 2023.
  • Hopewell Therapeutics raised $3M (Seed) on May 19, 2023.
  • LinusBio raised $8M on May 19, 2023.
  • Korsana Biosciences raised $5M on May 19, 2023.
  • Artelon raised $20M on May 19, 2023.
  • Alphyn Biologics raised $1.2M (Series A) on May 19, 2023.

Who to call at Sensible Biotechnologies, and when

A new round usually means Sensible Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sensible Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sensible Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sensible Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sensible Biotechnologies

Location

2093 Philadelphia Pike #3008

Oxford, England, United Kingdom

About

Sensible Biotechnologies is building a cell-based platform for the production of high-quality mRNA. Sensible's platform eliminates the major bottlenecks in the mRNA production process in an effort to unlock the full potential of mRNA technology for the next generation of therapeutics and vaccines. Sensible aims to become an integral part of the global biomanufacturing infrastructure and biosecurity framework. Sensible Biotechnologies is based in Oxford, United Kingdom, and in Bratislava, Slovakia. For further information, visit www.sensible.bio, and follow us on Twitter @sensible_bio.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sensible Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMiroslav, CEO and Co-Founder hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Sensible Biotechnologies's next move

See what Strategic adds

Sensible Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.